STAAR Surgical Company (STAA): Price and Financial Metrics

STAAR Surgical Company (STAA): $127.76

-4.12 (-3.12%)

POWR Rating

Component Grades














  • Growth is the dimension where STAA ranks best; there it ranks ahead of 99.83% of US stocks.
  • The strongest trend for STAA is in Growth, which has been heading up over the past 31 weeks.
  • STAA's current lowest rank is in the Value metric (where it is better than 20.84% of US stocks).

STAA Stock Summary

  • STAA's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 782.21 -- higher than 95.06% of US-listed equities with positive expected earnings growth.
  • STAA's current price/earnings ratio is 567.3, which is higher than 98.47% of US stocks with positive earnings.
  • Price to trailing twelve month operating cash flow for STAA is currently 174.5, higher than 97.62% of US stocks with positive operating cash flow.
  • Stocks that are quantitatively similar to STAA, based on their financial statements, market capitalization, and price volatility, are KRNT, TDC, CSPI, ARCE, and AMPH.
  • STAA's SEC filings can be seen here. And to visit Staar Surgical Co's official web site, go to

STAA Valuation Summary

  • STAA's EV/EBIT ratio is 443.7; this is 1454.12% higher than that of the median Healthcare stock.
  • Over the past 243 months, STAA's EV/EBIT ratio has gone up 447.1.
  • Over the past 243 months, STAA's price/sales ratio has gone up 38.5.

Below are key valuation metrics over time for STAA.

Stock Date P/S P/B P/E EV/EBIT
STAA 2020-08-04 17.7 16.4 215.6 284.0
STAA 2017-06-02 4.6 10.4 -61.2 -79.8
STAA 2016-06-15 2.9 5.9 -18.5 -17.4
STAA 2010-07-01 2.8 8.9 -199.5 100.3
STAA 2009-01-30 0.8 2.3 -3.2 -3.7
STAA 2008-01-18 1.2 1.8 -4.0 -3.7

STAA Price Target

For more insight on analysts targets of STAA, see our STAA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $138.00 Average Broker Recommendation 1.43 (Moderate Buy)

STAA Stock Price Chart Interactive Chart >

Price chart for STAA

STAA Price/Volume Stats

Current price $127.76 52-week high $161.71
Prev. close $131.88 52-week low $45.47
Day low $127.00 Volume 145,942
Day high $131.32 Avg. volume 611,639
50-day MA $139.36 Dividend yield N/A
200-day MA $105.69 Market Cap 5.99B

STAAR Surgical Company (STAA) Company Bio

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver lenses into the eye. The company was founded in 1982 and is based in Monrovia, California.

STAA Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$127.76$251.7 98%

We started the process of determining a valid price forecast for Staar Surgical Co with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Staar Surgical Co ranked in the 69th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 98.83%. As for the metrics that stood out in our discounted cash flow analysis of Staar Surgical Co, consider:

  • STAA's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 62.54% of tickers in our DCF set.
  • Relative to other stocks in its sector (Healthcare), Staar Surgical Co has a reliance on debt greater than just 4.59% of them.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Staar Surgical Co? See IIN, HAE, HCA, SUPN, and ALXN.

STAA Latest News Stream

Event/Time News Detail
Loading, please wait...

STAA Latest Social Stream

Loading social stream, please wait...

View Full STAA Social Stream

Latest STAA News From Around the Web

Below are the latest news stories about Staar Surgical Co that investors may wish to consider to help them evaluate STAA as an investment opportunity.

Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week

Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on five names. While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Staar Surgical Co. recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings.

Yahoo | July 25, 2021

3 Value Stocks That Won't Stop Growing

Growth stocks might grab headlines and excite the market, but sometimes they end up deflating just as quickly as they climbed. In contrast, value stocks are perfect for cautious investors because they tend to have business models that have stood the test of time. Since the start of the pandemic, Retractable Technologies (NYSEMKT: RVP) has been on a tear.

Yahoo | July 23, 2021

STAAR Surgical (STAA) Sees Hammer Chart Pattern: Time to Buy?

STAAR Surgical (STAA) has been struggling lately, but the selling pressure may be coming to an end soon.

Yahoo | July 22, 2021

STAAR Surgical to Report Second Quarter Results on August 4, 2021

LAKE FOREST, Calif., July 21, 2021--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the second quarter ended July 2, 2021 on Wednesday, August 4, 2021 after the market close.

Yahoo | July 21, 2021

What Makes Staar Surgical (STAA) a Strong Momentum Stock: Buy Now?

Does Staar Surgical (STAA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Yahoo | June 30, 2021

Read More 'STAA' Stories Here

STAA Price Returns

1-mo -16.38%
3-mo -6.15%
6-mo 23.02%
1-year 133.82%
3-year 293.71%
5-year 1,827.00%
YTD 61.27%
2020 125.25%
2019 10.22%
2018 105.87%
2017 42.86%
2016 51.96%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8947 seconds.